|
DHX15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.69079999954047E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.097060E-03 |
| Normal-vs-Stage2 |
7.763900E-03 |
| Normal-vs-Stage3 |
3.99720256893943E-11 |
| Normal-vs-Stage4 |
2.07479999847493E-08 |
| Stage1-vs-Stage2 |
7.274400E-01 |
| Stage1-vs-Stage3 |
3.2712999999962E-06 |
| Stage1-vs-Stage4 |
3.973100E-04 |
| Stage2-vs-Stage3 |
1.222030E-02 |
| Stage2-vs-Stage4 |
2.766100E-02 |
| Stage3-vs-Stage4 |
7.845600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21860000038099E-07 |
| Normal-vs-AfricanAmerican |
1.875720E-03 |
| Normal-vs-Asian |
9.119800E-01 |
| Caucasian-vs-AfricanAmerican |
4.516200E-01 |
| Caucasian-vs-Asian |
8.948200E-02 |
| AfricanAmerican-vs-Asian |
1.857360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.30099999848954E-09 |
| Normal-vs-Female |
2.017400E-03 |
| Male-vs-Female |
1.417540E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.675220E-03 |
| Normal-vs-Age(41-60Yrs) |
1.203400E-04 |
| Normal-vs-Age(61-80Yrs) |
6.43030000357925E-08 |
| Normal-vs-Age(81-100Yrs) |
1.083170E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.700400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.834600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.223600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.527570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.311200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.399000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.129800E-01 |
| Normal-vs-Grade 2 |
3.980000E-03 |
| Normal-vs-Grade 3 |
1.27720001241727E-09 |
| Normal-vs-Grade 4 |
2.65300004187452E-11 |
| Grade 1-vs-Grade 2 |
3.016200E-02 |
| Grade 1-vs-Grade 3 |
9.76659999999407E-05 |
| Grade 1-vs-Grade 4 |
2.57599999997637E-06 |
| Grade 2-vs-Grade 3 |
8.43790000000233E-05 |
| Grade 2-vs-Grade 4 |
2.96059999960185E-07 |
| Grade 3-vs-Grade 4 |
9.864700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.330100E-02 |
| Normal-vs-ccB subtype |
3.72629704870064E-11 |
| ccA subtype-vs-ccB subtype |
3.59030027929919E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.0666000000169E-06 |
| Normal-vs-N1 |
2.000300E-03 |
| N0-vs-N1 |
3.614600E-01 |
|
|
